Recent 8-K filings for GRUSF
Highest-materiality recent filing
Grown Rogue enters NY via JV, $15M financing commitment, plans PharmaCann NY acquisition
- Grown Rogue New York JV: capital partner invests $10M for 49% preferred equity; Grown Rogue holds 51%.
- Planned purchase price ~$4.5M ($3M at regulatory approval); plus $5M drawable term loan at 15%, $9M secured loan to PCNY.
-
Grown Rogue enters NY via JV, $15M financing commitment, plans PharmaCann NY acquisition
Grown Rogue New York JV: capital partner invests $10M for 49% preferred equity; Grown Rogue holds 51%.
-
Grown Rogue Q2 revenue up 41% to $11.3M; net loss $1.5M; guidance raised
Revenue $11.3M (+41% YoY); GAAP net loss $1.5M vs net income $1.7M in Q2 2025.
-
Grown Rogue partner SEA Craft restarts Illinois cultivation; first harvest expected Sept 2026
SEA Craft received Illinois approval on June 5, 2026, and restarted cultivation at the Dwight facility.
-
Grown Rogue Q1 2026 revenue up 28% to $9.2M, net loss $2.2M; raises 2026 revenue guidance to $34-37M
Revenue $9.2M (+28% YoY), GAAP net loss $2.2M vs income $0.7M a year ago; adjusted EBITDA $1.6M (17.1% margin).
-
Grown Rogue FY2025 revenue $32.4M (+22% YoY), Adj. EBITDA $5.4M; provides guidance
Full-year 2025 revenue $32.4M (+22% YoY), GAAP net income $3.2M includes $5.9M non-cash derivative gain.
-
Grown Rogue prelim FY2025 revenue $32.4M (+22%), Adj EBITDA $5.3M (+39%); net income turns positive
Preliminary 2025 revenue $32.4M (+22% YoY); net income $2.4M vs $16.1M loss in 2024.
-
Grown Rogue acquires 49% of Sea Craft for Illinois entry; $4M project capital
Acquired 49% of Sea Craft LLC for $1M seller note; option to buy remaining 51% for $250k-$1M.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.78 · Median 0.70 · Most common event earnings